secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2026-03-02T23:59:59+00:00
Accession:  0001522767-26-000011
Event type: debt
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 2.03, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed restructures $14.2M Series B obligation with $8M notes and 26.9M preferred shares
--------------------------------------------------------------------------------

- Old Series B preferred (4,908,333 shares) cancelled, avoiding ~$14.2M cash payout upon mandatory conversion on Feb 28, 2026.
- Issued $2M note due March 2028 at 8% and $6M note due March 2031 at 10% (reduces to 8% if $2M note repaid within 6 months).
- Issued 26.9M shares of new Series B Convertible Preferred Stock with $0.25/sh liquidation preference ($6.725M aggregate).
- New preferred ranks senior to common on dividends/liquidation; conversion options with VWAP-based mechanics.
- Restructuring extinguished all prior obligations to Navy Capital Green; no stockholder approval was required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276726000011/0001522767-26-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276726000011/mrmd-20260224.htm
  HTML page:      https://secwatch.observer/filing/0001522767-26-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer